Published in Diabetes Week, August 30th, 2004
Velcura, as part of its work developing therapies for bone diseases such as osteoporosis, investigates how human bone cells function. The grant was awarded by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) based on NIDDK's interests in endocrinology, metabolic diseases, and stem cells.
The grant funds research that investigates the control of stem cells found in the bone marrow of children and adults (as opposed to embryonic stem cells) and their relationship to early and mature bone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.